IO Biotech Inc.

IOBT
Date Form Type SEC Filings
Sep 17, 2024 SC 13D/A Profile Financial Statements
Sep 11, 2024 144 Profile Financial Statements
Aug 30, 2024 8-K Profile Financial Statements
Aug 13, 2024 8-K Profile Financial Statements
Jul 26, 2024 4 Profile Financial Statements
Jul 25, 2024 144 Profile Financial Statements
Jun 11, 2024 8-K Profile Financial Statements
May 14, 2024 SC 13G/A Profile Financial Statements
May 14, 2024 4 Profile Financial Statements
May 10, 2024 144 Profile Financial Statements
Apr 26, 2024 8-K Profile Financial Statements
Mar 22, 2024 10-K/A Profile Financial Statements
Feb 13, 2024 SC 13D/A Profile Financial Statements
Feb 13, 2024 4 Profile Financial Statements
Feb 13, 2024 SC 13G/A Profile Financial Statements
Feb 9, 2024 144 Profile Financial Statements
Jan 8, 2024 8-K Profile Financial Statements
Dec 18, 2023 SC 13G Profile Financial Statements
Nov 24, 2023 4 Profile Financial Statements
Nov 17, 2023 4 Profile Financial Statements
Nov 17, 2023 3 Profile Financial Statements
Sep 12, 2023 424B2 Profile Financial Statements
Sep 8, 2023 EFFECT Profile Financial Statements
Sep 7, 2023 SC 13G Profile Financial Statements
Sep 6, 2023 CORRESP Profile Financial Statements
Sep 6, 2023 UPLOAD Profile Financial Statements
Aug 30, 2023 S-3 Profile Financial Statements
Aug 15, 2023 SC 13G/A Profile Financial Statements
Aug 15, 2023 4 Profile Financial Statements
Aug 15, 2023 3 Profile Financial Statements
Aug 14, 2023 SC 13G/A Profile Financial Statements
Aug 14, 2023 SC 13D/A Profile Financial Statements
Aug 11, 2023 SC 13D/A Profile Financial Statements
Aug 11, 2023 4 Profile Financial Statements
Aug 10, 2023 4 Profile Financial Statements
Aug 9, 2023 4 Profile Financial Statements
Aug 7, 2023 8-K Profile Financial Statements
Jul 19, 2023 4 Profile Financial Statements
Jul 19, 2023 3 Profile Financial Statements
Jul 18, 2023 8-K Profile Financial Statements
Jun 14, 2023 8-K Profile Financial Statements
Jun 13, 2023 4 Profile Financial Statements
Mar 14, 2023 10-K Profile Financial Statements
Mar 31, 2022 10-K Profile Financial Statements